Page last updated: 2024-10-24
celecoxib and Long Sleeper Syndrome
celecoxib has been researched along with Long Sleeper Syndrome in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|
| Eloy, JD | 1 |
| Anthony, C | 1 |
| Amin, S | 1 |
| Caparó, M | 1 |
| Reilly, MC | 1 |
| Shulman, S | 1 |
Clinical Trials (1)
Trial Overview
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| The Effect of Gabapentin on Postoperative Pain: a Randomized, Double Blind, Placebo Controlled Trial[NCT01546857] | Phase 4 | 34 participants (Actual) | Interventional | 2012-03-31 | Terminated (stopped due to No longer able to recruit subjects due to unavailability of orthopedic surgeon.) |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Trial Outcomes
Opioid Consumption
Patient Controlled Analgesia use over 48 hours reported in Morphine equivalent dosage. (NCT01546857)
Timeframe: 48 hours post operatively
| Intervention | mg (Mean) |
|---|
| Placebo | 11.88 |
| Gabapentin | 11.02 |
Visual Analogue Scale for Pain
Severity of pain measure on a scale from zero to ten. Zero no pain to ten severe pain. (NCT01546857)
Timeframe: 48 hours post operatively
| Intervention | units on a scale (Mean) |
|---|
| Placebo | 5.15 |
| Gabapentin | 4.38 |
Quality of Sleep.
A questionnaire was administered asking participants about the quality of their sleep on the night of surgery asked on postoperative day 1, and on the first postoperative night ( POD 2) . Scored on a scale of zero to 3. Zero meaning poor postoperative sleep and 3 indicating better postoperative sleep. (NCT01546857)
Timeframe: Night of surgery (POD 1) and Postoperative Day 2.(POD 2)
| Intervention | units on a scale (Mean) |
|---|
| POD 1 | POD 2 |
|---|
| Gabapentin | 1.235 | 0.647 |
,| Placebo | 1.333 | 1 |
Trials
1 trial available for celecoxib and Long Sleeper Syndrome